PMLiVE RSS Feed: EuroVision blog RSS

PRIME Time in the EU

Mon, 17 Oct 2016 11:30:57 +0100

New pathway promises expedited approvals for innovative medicines

Europe's market access outlook

Thu, 15 Sep 2016 00:01:35 +0100

An ever-closer union?

Brexit: Medical research and the EU referendum

Fri, 20 May 2016 17:29:45 +0100

On 20 May, International Clinical Trials Day, we look at how the referendum could affect research in the UK

Safeguarding European research

Fri, 20 May 2016 00:03:59 +0100

How changes to EU clinical trials legislation will help

EFPIA: The patient is at the heart of what we do

Fri, 08 Aug 2014 11:16:10 +0100

And we are at the heart of economic growth, says Richard Bergström

Politically acceptable - a unified patent for Europe

Fri, 01 Aug 2014 00:15:36 +0100

But will Europe’s Unified Patent Court help or harm the pharma sector?

#resistpharma in Turkey

Wed, 25 Sep 2013 00:16:27 +0100

Pharma needs to refocus its efforts in the country after a period of decline

The digital dilemma for pharma in Turkey

Fri, 25 Jan 2013 15:46:11 +0000

Why Turkey’s pharma marketers currently feel they are taking a bit of a gamble going over to digital

Digital dreams - or just another nightmare?

Thu, 03 Jan 2013 00:15:30 +0000

Max Jackson on why digital satisfaction scores are so low

One scoop or two?

Thu, 23 Aug 2012 16:45:09 +0100

A parallel between local ice cream preferences and pharma brands will make you think twice against rolling out exclusive, one-for-all global marketing plans.

Is Europe heading for irrelevance in global pharma?

Thu, 02 Aug 2012 09:19:08 +0100

It’s a disturbing thought but is Europe becoming more and more irrelevant in the global pharmaceutical arena?

Talent: when will we ever learn?

Wed, 20 Jun 2012 15:45:06 +0100

Are we losing our future talent pool? Max can see some similarities to the previous recession…

Digital – still the perceived panacea?

Wed, 23 May 2012 15:01:11 +0100

Is industry stepping back from its digital foray? Maybe not entirely, but General Motors’ (GM) recent decision to “reassess” its Facebook advertising could reflect a more rational regard for the use of technology within our industry too

The (r)evolution of the digital agency

Tue, 01 May 2012 16:42:27 +0100

It seems every ‘traditional’ agency has had to have one – if only by association or acquisition. But rather than the ‘interactive agency’ ruling the world, Max Jackson sees something of a sea change…

Open dialogue and the industry – an unpalatable reality

Mon, 02 Apr 2012 16:37:42 +0100

With the closing of Janssen’s Psoriasis 360 Facebook page – Max explains why he believes that the social interaction websites are unsuited to prescription-only products. Add your comment, to say what you think.